
GLP-1s, Personalization, And Big Pharma Power Plays: What’s Really At Stake In The Eli Lilly Lawsuit
This lawsuit may look like a business dispute on the surface. But underneath, it’s about something much more important: the right of patients to receive personalized, affordable care.